Overweight , ObesityNCT07263243
Immediate Effect of Whole-Body Vibration on Cardiovascular Response and Functional Capacity in Overweight/Obese Young Women
A study testing Whole-body vibration device in people with Overweight , Obesity, run by Cairo University at 1 site in Saudi Arabia.
Trial summary
Obesity has become a major global public health issue, defined by an excessive accumulation of body fat that presents substantial health risks. Over 650 million adults worldwide suffer from obesity, which is defined as having a Body Mass Index (BMI) of 30 or higher. Read more about this study
- Who is it for?
- Ages 18 to 25 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Overweight , Obesity
- What is being tested?
- Whole-body vibration device
- Type of treatment
- Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 26 participants
- Where
- 1 siteSaudi Arabia
- Study dates
- 20 Feb 2026to 20 May 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 25 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Females aged 18 to 25.
- normotensive (<140/90 mmHg).
- Their BMI was from 25 to 40 kg/m2.
- Sedentary (≤ 90min of regular exercise per week).
Who cannot join
- Having previously diagnosed with any chronic disease.
- Cardiorespiratory or neuromuscular conditions.
- Participating in any exercise program.
- Patients with a pacemaker.
- Pregnancy.
- Smoking.
Trial locations and contacts
1 site in 1 country.
About this study
Obesity has become a major global public health issue, defined by an excessive accumulation of body fat that presents substantial health risks. Over 650 million adults worldwide suffer from obesity, which is defined as having a Body Mass Index (BMI) of 30 or higher. Obesity is becoming more common in both developed and developing countries. Sedentary lifestyles, unhealthy eating habits that include processed foods and sugars, and genetic factors are the main causes of the rising prevalence of obesity. Obesity is a multifactorial condition that affects physical appearance and self-esteem, while also having significant implications for long-term health, leading to decreased life expectancy and lower quality of life.
- Conditions
- Overweight , Obesity
- Being tested
- Whole-body vibration device, Sham whole body vibration
- Medical subject headings
- Overweight, Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Whole-body vibration deviceDevice
Whole-body vibration (WBV) training using the Power Plate Pro 7HC (Northbrook, USA). The vibration frequency was set at 30 Hz, with an amplitude of 2 mm.
Sham whole body vibrationOther
A sham Whole body vibration will be used . participants will stand on the device without actual vibrations.This control condition will be used to isolate the effects of WBV from other potential influences such as standing posture and time spent on the the platform.
| Study group | Role | What they receive |
|---|---|---|
| Study Group (Whole body vibration group) | Experimental | The study group (no = 13) underwent single session of whole-body vibration (WBV) of using the PowerPlate device. Receives: Device: Whole-body vibration device |
| Control group (Sham whole body vibration group) | Experimental | The sham WBV group (no=13) will stand on the same device with the vibtation shut off for single session. Receives: Other: Sham whole body vibration |
What is being measured
The primary outcome is the main question the study is designed to answer.
Brachial blood pressure
Systolic brachial blood pressure and diastolic brachial blood pressure will be measured using a blood pressure (BP) monitoring device after 15 minutes rest.
Measured: 1 day
Heart rate
Heart rate will be measured using a pulse oximeter after 15 minutes rest.
Measured: 1 day
Arterial O2 saturation
Arterial oxygen saturation of pulse oximetry (SpO2) were measured using a pulse oximeter.
Measured: 1 day
Secondary outcomes (2)
6-Minute walk test
The 6-Minute Walk Test (6MWT) is a simple, practical assessment used to measure functional exercise capacity. It evaluates how far a person can walk on a flat, hard surface (usually 30 meters) in six minutes. It is widely used in cardiology, pulmonology, and rehabilitation.
Measured: 1 day
The Borg scale
The Borg Scale is a tool used to measure a person's perceived exertion and how hard they feel they are working during physical activity. It is commonly used during cardiac rehab, pulmonary rehab, exercise training, and clinical assessments. the scale ranges from 6 represents no exertion at all and to 20 represents maximal exertion.
Measured: 1 day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Dec 2025
- Study start20 Feb 2026
- Primary completion20 May 2026
- Study completion20 May 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Overweight , ObesityStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 26 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Rokaia Ali Zainelabedeen Mohamed Toson, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07263243
- Sponsor's protocol ID
- 7699
- Status last verified
- Aug 2026
- First submitted
- 23 Nov 2025
- Last updated
- 19 Aug 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 19 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Immediate Effect of Whole-Body Vibration on Cardiovascular Response and Functional Capacity in Overweight/Obese Young Women
- ClinicalTrials.gov ID
- NCT07263243
- Acronym / sponsor ID
- 7699
- Conditions
- Overweight , Obesity
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 26 participants (actual)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 20 Feb 2026 (actual)
- Primary completion
- 20 May 2026 (actual)
- Study completion
- 20 May 2026 (actual)
- First posted
- 4 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Obesity has become a major global public health issue, defined by an excessive accumulation of body fat that presents substantial health risks. Over 650 million adults worldwide suffer from obesity, which is defined as having a Body Mass Index (BMI) of 30 or higher. Obesity is becoming more common in both developed and developing countries. Sedentary lifestyles, unhealthy eating habits that include processed foods and sugars, and genetic factors are the main causes of the rising prevalence of obesity. Obesity is a multifactorial condition that affects physical appearance and self-esteem, while also having significant implications for long-term health, leading to decreased life expectancy and lower quality of life.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Study Group (Whole body vibration group) | Experimental | Device: Whole-body vibration deviceThe study group (no = 13) underwent single session of whole-body vibration (WBV) of using the PowerPlate device. |
| Control group (Sham whole body vibration group) | Experimental | Other: Sham whole body vibrationThe sham WBV group (no=13) will stand on the same device with the vibtation shut off for single session. |
Who may qualify
- Ages
- 18 to 25 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Females aged 18 to 25.
- normotensive (<140/90 mmHg).
- Their BMI was from 25 to 40 kg/m2.
- Sedentary (≤ 90min of regular exercise per week).
Key exclusion criteria (6 listed)
- Having previously diagnosed with any chronic disease.
- Cardiorespiratory or neuromuscular conditions.
- Participating in any exercise program.
- Patients with a pacemaker.
- Pregnancy.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Whole-body vibration deviceWhole-body vibration (WBV) training using the Power Plate Pro 7HC (Northbrook, USA). The vibration frequency was set at 30 Hz, with an amplitude of 2 mm. | Device | Study Group (Whole body vibration group) |
| Sham whole body vibrationA sham Whole body vibration will be used . participants will stand on the device without actual vibrations.This control condition will be used to isolate the effects of WBV from other potential influences such as standing posture and time spent on the the platform. | Other | Control group (Sham whole body vibration group) |
Primary outcome
Brachial blood pressure
Time frame: 1 day
Systolic brachial blood pressure and diastolic brachial blood pressure will be measured using a blood pressure (BP) monitoring device after 15 minutes rest.
Heart rate
Time frame: 1 day
Heart rate will be measured using a pulse oximeter after 15 minutes rest.
Arterial O2 saturation
Time frame: 1 day
Arterial oxygen saturation of pulse oximetry (SpO2) were measured using a pulse oximeter.
2 secondary outcomes
6-Minute walk test
Time frame: 1 day
The Borg scale
Time frame: 1 day
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Aug 2026.
- Individual participant dataSharing planned: Yes
Related trials for Overweight , Obesity
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
Active, not recruitingPhase 4
Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders
Metabolic Abnormalities, Obesity & Overweight
Recruiting
Exercise Training and Vitamin D Metabolism
Obesity & Overweight, Vitamin D
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Active, not recruiting
Effect of Probiotics on Insulin Sensitivity in Overweight and Obese Pregnancy
Obesity & Overweight, Gestational Diabetes Mellitus (GDM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Whole-body vibration device in people with Overweight , Obesity, run by Cairo University at 1 site in Saudi Arabia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Brachial blood pressure (time frame: 1 day). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2026.